Press Release November 22, 2021Merck KGaA, Darmstadt, Germany Highlights Novel Mechanisms with the Potential to Transform Standards of Care in Several Cancers, MS, and Lupus 0 0 Share
Press Release November 19, 2021EU Backs Merck's COVID-19 Pill For Adults At Risk Of Severe Illness 0 0 Share
Company Ticker News November 19, 2021Merck Completes Tender Offer to Acquire Acceleron Pharma Inc. 0 0 Share
Press Release November 19, 2021Will Pfizer's COVID Pill Crush the Hopes of Merck Investors? 0 0 Share
Press Release November 18, 2021Merck Provides Update on Phase 2 Clinical Trial of Once-Weekly Investigational Combination of MK-8507 and Islatravir for the Treatment of People Living with HIV-1 0 0 Share
Press Release November 18, 2021FDA Approves Merck's KEYTRUDA® (pembrolizumab) as Adjuvant Therapy for Certain Patients With Renal Cell Carcinoma (RCC) Following Surgery 0 0 Share
